万泰生物 (603392.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

7.0x

EV/EBITDA

−251.5x

Market Cap

CNY 35.52B

MomentumView details →

1D Return

−8.17%

YTD Return

−38.43%

RSI (14)

41.8

ValuationView details →

P/E (Fwd)

7.0x

EV/EBITDA

−251.5x

Market Cap

CNY 35.52B

RSI (14)

41.8

MomentumView details →

1D Return

−8.17%

YTD Return

−38.43%

ProfitabilityView details →

Gross Margin

51.30%

Net Margin

−20.01%

EBITDA Margin

−6.77%

ROE (TTM)

−3.29%

ROA (TTM)

−2.82%

Asset Turnover

0.14x

GrowthView details →

Revenue YoY

+2.54%

EPS YoY

—

FCF YoY

−33.09%

Revenue CAGR 3Y

−45.42%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

4.21x

Quick Ratio

3.73x

Div Yield

—

Div Rate

—

Div Growth 1Y

−55.20%

Financials snapshotView financials →

Revenue (TTM)

1.94B

Net Income (TTM)

−388.47M

Op. CF (TTM)

−56.32M

Next earningsOct 23, 2026 →

Latest newsMore news →

Wantai Biological announced its first-half 2026 results: revenue of 1.048 billion yuan, up 24.29% year-on-year, and a net loss attributable to shareholders of 128 million yuan, compared with a loss of 144 million yuan in the same period last year.17d ago

Wantai Biological's director and general manager JIANG ZHIMING resigned on July 2, 2026, and chairman Qiu Zixin will temporarily assume the general manager duties.64d ago

Similar companies

Alnylam Pharmaceuticals, Inc.ALNY 君实生物-U688180.SH Shanghai Henlius Biotech, Inc.02696.HK 三生国健688336.SH 3SBio Inc.01530.HK 泽璟制药-U688266.SH Find similar companies →

Latest newsMore news →

Wantai Biological announced its first-half 2026 results: revenue of 1.048 billion yuan, up 24.29% year-on-year, and a net loss attributable to shareholders of 128 million yuan, compared with a loss of 144 million yuan in the same period last year.17d ago Wantai Biological's director and general manager JIANG ZHIMING resigned on July 2, 2026, and chairman Qiu Zixin will temporarily assume the general manager duties.64d ago